Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic Acid
2. Ono 5046
3. Ono-5046
4. Ono-ei-600
5. Sivelestat
1. Sivelestat Sodium Tetrahydrate
2. 201677-61-4
3. Sivelestat Sodium Hydrate
4. Elaspol
5. Ono-5046.na
6. Ly544349 Sodium Hydrate
7. Sivelestat (sodium Tetrahydrate)
8. Sivelestat Sodium [usan]
9. Ei-546
10. Ono 5046
11. Sivelestat Sodium (usan)
12. Ono-5046 Sodium Hydrate
13. Sivelestat Sodium Salt Tetrahydrate
14. Ly-544349 Sodium Hydrate
15. 737rr8y409
16. Sodium;2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate;tetrahydrate
17. Dsstox_cid_26727
18. Dsstox_rid_81857
19. Dsstox_gsid_46727
20. Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-, Monosodium Salt, Tetrahydrate
21. Sodium ((2-(((4-((2,2-dimethylpropanoyl)oxy)phenyl)sulfonyl)amino)benzoyl)amino)acetate Tetrahydrate
22. Ono5046-na;sodium Sivelestat;ei546 Sodium;ly544349 Sodium
23. Sodium Sivelestat
24. Sodium 2-(2-(4-(pivaloyloxy)phenylsulfonamido)benzamido)acetate Tetrahydrate
25. Ei546 Sodium Tetrahydrate;ly544349 Sodium Tetrahydrate;ono5046 Sodium Tetrahydrate
26. Sodium,2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate,tetrahydrate
27. Elaspol (tn)
28. Ei546 Sodium
29. Cas-201677-61-4
30. Ly544349 Sodium
31. Ncgc00167577-01
32. Ono5046-na
33. Unii-737rr8y409
34. Sivelestatsodiumhydrate
35. Elaspol Sodium Salt Tetrahydrate
36. Chembl3182314
37. Dtxsid0046727
38. Chebi:32133
39. Sivelestat (sodium Salt Hydrate)
40. Sivelestat Sodium [mart.]
41. Sivelestat Sodium Hydrate (jp17)
42. Sivelestat Sodium [who-dd]
43. Act02667
44. Bcp09535
45. Tox21_112570
46. Hy-17443b
47. S4666
48. Akos015901086
49. Akos015963357
50. Tox21_112570_1
51. Ac-1291
52. Ccg-269903
53. Cs-3380
54. Sivelestat Sodium Hydrate [jan]
55. Sivelestat Sodium For Injection (jp17)
56. Ncgc00263570-01
57. Ft-0748809
58. D01918
59. Sivelestat Sodium Salt Tetrahydrate [mi]
60. A909240
61. J-013081
62. Q27266149
63. Sodium ((2-(((4-((2,2-dimethylpropanoyl)oxy)phenyl)sulfonyl)amino)benzoyl)amino)acetate Tetrahydrate
Molecular Weight | 528.5 g/mol |
---|---|
Molecular Formula | C20H29N2NaO11S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 9 |
Exact Mass | 528.13897520 g/mol |
Monoisotopic Mass | 528.13897520 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 738 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 6 |
Serine Proteinase Inhibitors
Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
61
PharmaCompass offers a list of Sivelestat Sodium Hydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sivelestat Sodium Hydrate manufacturer or Sivelestat Sodium Hydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sivelestat Sodium Hydrate manufacturer or Sivelestat Sodium Hydrate supplier.
PharmaCompass also assists you with knowing the Sivelestat Sodium Hydrate API Price utilized in the formulation of products. Sivelestat Sodium Hydrate API Price is not always fixed or binding as the Sivelestat Sodium Hydrate Price is obtained through a variety of data sources. The Sivelestat Sodium Hydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate, including repackagers and relabelers. The FDA regulates EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate supplier is an individual or a company that provides EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate active pharmaceutical ingredient (API) or EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate finished formulations upon request. The EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate suppliers may include EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate API manufacturers, exporters, distributors and traders.
click here to find a list of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate active pharmaceutical ingredient (API) in detail. Different forms of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate DMFs exist exist since differing nations have different regulations, such as EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate DMF submitted to regulatory agencies in the US is known as a USDMF. EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate USDMF includes data on EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate Drug Master File in Japan (EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate JDMF) empowers EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate JDMF during the approval evaluation for pharmaceutical products. At the time of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate suppliers with JDMF on PharmaCompass.
EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate GMP manufacturer or EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate GMP API supplier for your needs.
A EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate CoA (Certificate of Analysis) is a formal document that attests to EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate's compliance with EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate specifications and serves as a tool for batch-level quality control.
EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate CoA mostly includes findings from lab analyses of a specific batch. For each EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate EP), EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EI546 sodium tetrahydrate;LY544349 sodium tetrahydrate;ONO5046 sodium tetrahydrate USP).